OSSIO received a contract with Vizient, making the company’s portfolio of bio-integrative OSSIOfiber® products available at negotiated pricing to healthcare providers in Vizient’s group purchasing organization (GPO) under a three-year contract starting March 1.
The contract covers the entire OSSIOfiber Intelligent Bone Regeneration Technology portfolio currently commercialized and cleared by FDA. These products include sterile, disposable instrument kits:
- OSSIOfiber Hammertoe Fixation System – 10-degree and straight implants in 2.5mm, 2.9mm and 3.2mm sizes.
- OSSIOfiber Trimmable Fixation Nails – Solid-core in 2.4mm and 4.0mm sizes and cannulated in 3.0mm and 4.0mm sizes.
- OSSIOfiber Compression Screws – Headless, cannulated, partially threaded configurations in 4.0mm diameter and lengths from 26–60mm.
OSSIOfiber Intelligent Bone Regeneration Technology provides a solution to the shortcomings of permanent metal hardware, conventional resorbable and allograft implants, and combines mechanical strength and natural bone healing in a non-permanent implant. Made from a proprietary natural mineral fiber matrix, its bio-integrative material properties provide surgeons with a more biologically friendly way to restore patient stability and mobility while leaving nothing permanent behind.
Beginning March 1, OSSIOfiber products are available to all members of Vizient at contracted pricing. Vizient is the largest member-driven healthcare performance improvement company in the U.S., with a diverse membership and customer base including academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute healthcare providers.
OSSIOfiber Intelligent Bone Regeneration Technology can address many surgical applications through the manufacturing of endless implant designs, including nails, screws, staples, anchors and plates. The company intends to pursue multiple applications in the distal extremity, trauma, sports, reconstruction, pediatrics and spine segments.